AnHeart Therapeutics and Innovent Announce China s NMPA Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.